Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding

By Imberti D.  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 102-108

Springer Publishing Company

Access to resources Recommend Favorite

Platelet-Induced Thrombin Generation Time II (PITT II) A Modified Global Coagulation Test to Monitor Prophylactic Anticoagulation with Vitamin K Antagonists? - A United Kingdom field study of two widely used coagulometers

By Radziwon P.   Boczkowska-Radziwon B.   Schenk J.F.   Wojtukiewicz M.Z.   Kloczko J.   Giedrojc J.   Breddin H.K.  

Thrombosis Research, Vol. 96, Iss. 1, 1999-10 ,pp. : 77-81

Elsevier

Access to resources Recommend Favorite

Safety and Efficacy of Novel Oral Anticoagulants: A Comparison to Vitamin K Antagonists

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 12, Iss. 1, 2014-04 ,pp. : 9-13

Bentham Science Publishers

Access to resources Recommend Favorite

Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases

By Denas G.   Marzot F.   Offelli P.   Stendardo A.   Cucchini U.   Russo R.   Nante G.   Iliceto S.   Pengo Vittorio  

Journal of Thrombosis and Thrombolysis, Vol. 27, Iss. 3, 2009-04 ,pp. : 340-347

Springer Publishing Company

Access to resources Recommend Favorite

Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure

By Lee Andrea   Crowther Mark  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 3, 2011-04 ,pp. : 249-258

Springer Publishing Company

Access to resources Recommend Favorite